Macrogenics (MGNX) Interest Expenses (2012 - 2026)
Macrogenics' (MGNX) quarterly Interest Expenses came in at $5.5 million in Q1 2026, up 5909.89% year-on-year from $91000.0 in Q1 2025, and up 28.02% on a QoQ basis from $4.3 million in Q4 2025.
Macrogenics (MGNX) Interest Expenses (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Interest Expenses data on file, last reported at $5.5 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 5909.89% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 7391.78% increase from a year earlier, with the FY2025 full-year figure at $8.5 million, down 97.88% from the prior year.
- Interest Expenses for Q1 2026 stood at $5.5 million, up from $4.3 million in the prior quarter.
- Over the last five years, Interest Expenses for MGNX reached as high as $46.4 million in Q1 2024 and fell as low as -$24000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $6.5 million across 5 years, with a median of $2.1 million in 2023.
- On a YoY basis, Interest Expenses climbed as much as 17900.0% in 2025 and fell as far as 99.8% in 2025.
- Year by year, Interest Expenses stood at $904000.0 in 2022, then soared by 131.53% to $2.1 million in 2023, then sank by 101.15% to -$24000.0 in 2024, then jumped by 17900.0% to $4.3 million in 2025, then gained by 28.02% to $5.5 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $5.5 million in Q1 2026, $4.3 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Macrogenics | 230.64 Mn | 164.12 Mn | - | 5.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.47 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 802,000.00 |
| Jun 30, 2025 | 802,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 46.45 Mn |
| Mar 31, 2024 | 46.45 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 7.83 Mn |
| Mar 31, 2023 | 7.83 Mn |